机译:青少年自发性和系统性评估的自杀性不良事件的预测因子(青少年抗SSRI抵抗)(TORDIA)研究
David A. Brent, M. D.Graham J. Emslie, M. D.Greg N. Clarke, Ph.D.Joan Asarnow, Ph.D.Anthony Spirito, Ph.D.Louise Ritz, M.B.A.Benedetto Vitiello, M. D.Satish lyengar, Ph.D.Boris Birmaher, M. D.Neal D. Ryan, M. D.Jamie Zelazny, M. P.M., R.N.Matthew Onorato, L.C.S.W.Betsy Kennard, Psy.D.Taryn L Mayes, M.S.Lynn L DeBar, Ph.D.James T. McCracken, M. D.Michael Strober, Ph.D.Robert Suddath, M.D.Henrietta Leonard, M.D.Giovanna Porta, M.S.Martin B. Keller, M.D.Received July 1, 2008, revision received Oct. 3, 2008, accepted Nov. 6, 2008 (doi: 10.1176/appl.ajp.2008.08070976). From the University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic. Address correspondence and reprint requests to Dr. Brent, University of Pittsburgh School of Medicine, Western University School of Medicine, Western Psychiatric Institute and Clinic, 3811 O'Hara St., Suite 112, Pittsburgh, PA, 15213-2593, brentda@upmc.edu (e-mail).Dr. Asarnow has consulted on cognitive behavior therapy and cognitive behavior therapy for depression on an unrestricted grant from Pfizer, has funding from Philip Morris, a family member has funding from Bristol-Myers Squibb and has consulted for Roche. Dr. Birmaher has participated in forums sponsored by Solvay Pharmaceuticals, Inc. and Abcomm, Inc. He presented on bipolar disorders in children at a meeting sponsored by Solvay. Dr. Birmaher also received royalties from Random House, Inc. Dr. Emslie receives research support from Biobehavioral Diagnostics Inc., Forest Laboratories, Shire, and Somerset, and is a consultant for Biobehavioral Diagnostics, Inc., Eli Lilly, Forest Laboratories, Inc., Shire, Validus Pharmaceuticals, and Wyeth Pharmaceuticals. Dr. Hughes is a consultant for Biobehavioral Diagnostics, Inc. Dr. Keller has reported research support from Pfizer. He is a consultant with CENEREX, Cephalon, Cypress Bioscience, Cyberonics, Forest Laboratories, Janssen, JDS, Organon, Novartis, Pfizer, and Wyeth. Or. Keller has served on advisory boards for Abbott Laboratories, Bristol-Myers Squibb, CENEREX, Cyberomcs, Cypress Bioscience, Forest Laboratories, Janssen, Novartis, Organon, and Pfizer. Dr. McCracken has received research support from Eli Lilly, McNeil, Bristol-Myers Squibb, and Shire. He is a consultant for Shire, Eli Lilly, McNeil, Pfizer, Janssen, Johnson & Johnson, Novartis and Wyeth. Dr. Wagner is a consultant or serves on the advisory board for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Johnson & Johnson, Otsuka, Solvay, and Wyeth. All other authors report no competing interests.Dr. Leonard passed away in August 2007.,;
机译:研究青少年自发性和系统评估的自杀性不良事件的预测因子(TORDIA)。
机译:自发性和系统评估的预测因子治疗青少年(Tordia)研究中SSRI抗性抑郁症的自身不良事件(Vol 166,PG 418,2009)
机译:FKBP5基因多态性与自杀事件在青少年抗抑郁药的治疗中的关联(TORDIA)研究。
机译:低频重复经颅磁刺激治疗对抑制青少年非自杀自损伤的影响
机译:美国的青少年抑郁和自杀倾向:过去十年中作为预测因素的YRBS概况和健康风险行为
机译:青少年自发性和系统评估的自杀性不良事件的预测因子(抗精神分裂症抵抗性抑郁症的治疗)(TORDIA)研究
机译:抑郁症研究(TADS)治疗青少年的自杀事件